-
JNJ's Shareholders Vote In Favor of Executive Pay (JNJ)
Thursday, April 28, 2011 - 10:25am | 20Johnson & Johnson 's (NYSE: JNJ) shareholders vote in favor of executive pay.
-
CEOWORLD top 6 buy Materials stocks list for 28 April- SWC, SSRI, SLW, AAU, ROC, FCX
Thursday, April 28, 2011 - 9:26am | 1144Stillwater Mining Company (NYSE:SWC)- Stillwater Mining Company is engaged in the development, extraction, processing, refining and marketing of palladium, platinum and associated metals (platinum group metals (PGMs)) from a geological formation in south central Montana known as the J-M Reef and...
-
UPDATE: Piper Jaffray Color On WPI Target Increase
Thursday, April 28, 2011 - 9:16am | 161Piper Jaffray, which raised its PT on shares of Watson Pharmaceuticals Inc. (NYSE: WPI), is providing some color on the stock. “Watson's 1Q11 results were solid, with generics continuing to outperform, particularly on gross margins, coming in at 52% (versus 47% in 1Q10),” Piper Jaffray writes. “...
-
Top five companies Stocks in the Specialty Chemicals industry- ROC, NLC, CYT, FOE, ECL
Thursday, April 28, 2011 - 9:14am | 12001) Rockwood Holdings (NYSE:ROC) ranks first with a gain of 10.09%- The company reported net income of $178 million, or $2.24 a share, for the three months ended March 31. That compares with net income of $36.9 million, or 48 cents a share, in the same quarter last year. The results included a $...
-
Merck and Inspire Announce Expiration of Hart-Scott-Rodino Act Waiting Period Relating to Tender Offer for Shares of Inspire (ISPH, MRK)
Thursday, April 28, 2011 - 8:34am | 156Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended has expired in connection with the previously announced cash...
-
Adolor Reports EPS of $(0.16) vs. $(0.16) Estimate; Revenues $9.03M vs. $9.1M Estimate (ADLR)
Thursday, April 28, 2011 - 8:05am | 21Adolor (NASDAQ: ADLR) Reports EPS of $(0.16) vs. $(0.16) Estimate; Revenues $9.03M vs. $9.1M Estimate
-
Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 (PFE)
Thursday, April 28, 2011 - 8:03am | 79Pfizer (NYSE: PFE) announced today top-line results from the ORAL Standard and ORAL Step Phase 3 studies of tofacitinib, an investigational, novel, oral JAK inhibitor. ORAL Standard is a completed twelve-month study in patients with moderate-to-severe active rheumatoid arthritis who had an...
-
Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 Trials Of Tofacitinib In Patients With Active Rheumatoid Arthritis
Thursday, April 28, 2011 - 8:01am | 80Pfizer Inc. (NYSE: PFE) announced today top-line results from the ORAL Standard and ORAL Step Phase 3 studies of tofacitinib, an investigational, novel, oral JAK inhibitor. ORAL Standard is a completed twelve-month study in patients with moderate-to-severe active rheumatoid arthritis who had an...
-
UPDATE: Bristol-Myers Squibb Reports Better-Than-Expected Q1 Results
Thursday, April 28, 2011 - 7:54am | 80Bristol-Myers Squibb Co (NYSE: BMY) reported upbeat results for the first quarter on Thursday. The company's quarterly profit increased to $986 million, or $0.57 per share, from $743 million, or $0.43 per share. The company's net sales surged to $5.01 billion, from $4.81 billion. However,...
-
Using Zignals Stock Screener to Search for UK Stocks
Thursday, April 28, 2011 - 7:41am | 2493This is in response to a feedback we received from one of our U.K. members. Hi I am looking to use your stock screener in a slightly different way that it seems to be set up for. For example I would like to find the top 30 shates in the FTSE by Market Cap. From that 30 I would like to select 10...
-
ViroPharma Reports EPS of $0.40 vs. $0.41 Estimate; Revenues $127M vs. $123.3M Estimate (VPHM)
Thursday, April 28, 2011 - 7:36am | 21ViroPharma (NASDAQ: VPHM) Reports EPS of $0.40 vs. $0.41 Estimate; Revenues $127M vs. $123.3M Estimate
-
Piper Jaffray Raises PT On Watson Pharmaceuticals To $72
Thursday, April 28, 2011 - 7:35am | 27Piper Jaffray has raised the price target on Watson Pharmaceuticals (NYSE: WPI) from $62 to $72 and maintains its Overweight rating.
-
ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial (ISTA)
Thursday, April 28, 2011 - 7:33am | 147ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced positive, topline results from its Phase 2 dose-ranging, environmental clinical trial of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused...
-
Bristol-Myers Squibb Reports EPS of $0.58 vs. $0.53 Estimate; Revenues $5.01B vs. $4.95B Estimate (BMY)
Thursday, April 28, 2011 - 7:30am | 22Bristol-Myers Squibb (NYSE: BMY) Reports EPS of $0.58 vs. $0.53 Estimate; Revenues $5.01B vs. $4.95B Estimate
-
US Stock Futures Mixed As Investors Await GDP Data, Earnings Reports
Thursday, April 28, 2011 - 6:26am | 576US stock futures are mixed this morning, as investors are awaiting key gross domestic product data and earnings reports from several companies. Futures on the Dow Jones Industrial Average gained 2 points to 12,643.00 and S&P 500 index futures rose 0.10 point to 1,351.10. Futures on the Nasdaq...